查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561466

2024-2032 年按药物类型（NSAID、DMARD、生物製剂等）、类型、给药途径、配销通路和地区分類的银屑病关节炎治疗市场报告

Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球干癣性关节炎治疗市场规模达97IMARC Group美元。

银屑病关节炎是一种自体免疫疾病，免疫系统攻击关节并引起发炎。其治疗选择多种多样，从减少肿胀和发炎的口服药物到针对特定免疫系统的生物疗法。根据疼痛、肿胀和僵硬的程度进行治疗。目前，主要参与者正在引入新的治疗方法，以帮助预防疾病进展、减轻疼痛、保护关节和维持活动范围。这些方法可以与物理治疗相结合，以增强肌肉和关节并提高整体稳定性。

银屑病关节炎治疗市场趋势：

银屑病是干癣性关节炎的主要危险因子之一。因此，由于感染、压力、肥胖、皮肤损伤、酗酒和维生素缺乏而导致的牛皮癣盛行率不断上升，是对市场产生正面影响的主要因素之一。此外，由于干癣性关节炎最常发生在 30 岁至 50 岁之间的人群中，全球成年人口的不断增长也促进了市场的成长。除此之外，患有干癣性关节炎的儿童更有可能患上影响眼壁组织中层的葡萄膜炎。再加上父母对孩子健康的日益担忧，刺激了全球对干癣性关节炎治疗的需求。此外，人们越来越认识到早期诊断和治疗干癣性关节炎的好处（例如预防严重损害）正在推动市场成长。其他因素，例如个人可支配收入的增加、医疗保健设施的改善以及个人健康意识的增强，预计将推动对新型干癣性关节炎治疗方法的需求，以对抗严重的症状。

本报告回答的关键问题：

  • 迄今为止，全球干癣性关节炎治疗市场表现如何，未来几年将如何表现？
  • COVID-19 对全球干癣性关节炎治疗市场有何影响？
  • 主要区域市场有哪些？
  • 根据药物类型分類的市场是怎么样的？
  • 依类型划分市场是怎么样的？
  • 根据给药途径，市场的分化为何？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球干癣性关节炎治疗市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球银屑病关节炎治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类型

  • NSAID（非类固醇抗发炎药）
    • 市场趋势
    • 市场预测
  • DMARD（缓解疾病的抗风湿药物）
    • 市场趋势
    • 市场预测
  • 生物製剂
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按类型

  • 处方
    • 市场趋势
    • 市场预测
  • 场外交易
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依管理途径

  • 可注射
    • 市场趋势
    • 市场预测
  • 口服
    • 市场趋势
    • 市场预测
  • 专题
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药局
    • 市场趋势
    • 市场预测
  • 网路药局
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Johnson & Johnson Service ltd.
    • Novartis AG
    • Pfizer Inc.
    • Samsung Biologics
    • UCB SA
Product Code: SR112024A4541

The global psoriatic arthritis treatment market size reached US$ 9.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

Psoriatic Arthritis Treatment Market Trends:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global psoriatic arthritis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug type, type, route of administration and distribution channel.

Breakup by Drug Type:

  • NSAIDs (Nonsteroidal Anti-Inflammatory drugs)
  • DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others

Breakup by Type:

  • Prescription
  • OTC

Breakup by Route of Administration:

  • Injectable
  • Oral
  • Topical

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

Key Questions Answered in This Report:

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Psoriatic Arthritis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Prescription
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 OTC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amneal Pharmaceuticals LLC
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 AstraZeneca plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eisai Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Eli Lilly and Company
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Service ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Samsung Biologics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 UCB S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2023
  • Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
  • Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
  • Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
  • Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players